Skip to content
buyModerate

Nancy T Chang bought $500k of GRTX

director, owner at Galera Therapeutics, Inc.. 7,644,932 shares at an average of $0.07, traded Dec 30, 2024, filed Jan 2, 2025.

Conviction score
41
Value
$500k
7,644,932 shares
Holdings after
7,644,932
change unknown
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Director
    +15
  • Trade size
    $500k at market
    +18
  • Relative to holdings
    First purchase: no shares before this trade
    +8
  • Price context
    No price history yet
    0
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0000905148-25-000010, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 30, 2024POpen-market purchase
Common Stock
+7,644,932$0.07$500k7,644,932Jan 2, 2025
Dec 30, 2024AGrant or award
Series B Preferred Stockderivative
+1,842$0.00$01,842Jan 2, 2025

Related signals

Other insiders at Galera Therapeutics, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
35Weak
GRTXsell
Galera Therapeutics, Inc.
Mel Sorensen
President and CEO
$1,407
70,000 shares
-26%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Nancy T Chang bought $500k of GRTX | InsiderTell